We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
Cap. Flow
+$723M
Cap. Flow %
2.6%
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175

Sector Composition

Rank Sector Weight
1 Financials 4.74%
2 Technology 4.11%
3 Healthcare 2.19%
4 Energy 2.03%
5 Consumer Discretionary 1.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGC
1876
CALL
Canopy Growth
CGC
$375M
$7K ﹤0.01%
200
LVS icon
1877
CALL
Las Vegas Sands
LVS
$30.5B
$7K ﹤0.01%
1,000
PGEN icon
1878
CALL
Precigen
PGEN
$1.93B
$7K ﹤0.01%
30,000
QQQ icon
1879
PUT
Invesco QQQ Trust
QQQ
$455B
$7K ﹤0.01%
2,000
+500
+33% +$84.8K
TSLA icon
1880
PUT
Tesla
TSLA
$1.24T
$7K ﹤0.01%
12,000
-12,000
-50% -$241K
NOW icon
1881
CALL
ServiceNow
NOW
$102B
$6K ﹤0.01%
1,500
-500
-25% -$22K
TRV icon
1882
PUT
Travelers Companies
TRV
$80.8B
$6K ﹤0.01%
2,000
JNJ icon
1883
CALL
Johnson & Johnson
JNJ
$634B
$5K ﹤0.01%
400
+300
+300% +$40.2K
MDB icon
1884
CALL
MongoDB
MDB
$24B
$5K ﹤0.01%
+100
New +$10.3K
SWKS icon
1885
CALL
Skyworks Solutions
SWKS
$9.06B
$5K ﹤0.01%
10,000
TTD icon
1886
PUT
Trade Desk
TTD
$8.13B
$5K ﹤0.01%
+10,000
New +$164K
AKAO
1887
DELISTED
Achaogen Inc
AKAO
$5K ﹤0.01%
10,660
ABT icon
1888
CALL
Abbott
ABT
$180B
$4K ﹤0.01%
100
BLRX
1889
BioLineRX
BLRX
$12.3M
$4K ﹤0.01%
17
CCI icon
1890
CALL
Crown Castle
CCI
$32.7B
$4K ﹤0.01%
+200
New +$23.5K
GILD icon
1891
CALL
Gilead Sciences
GILD
$161B
$4K ﹤0.01%
1,400
-1,700
-55% -$113K
MDT icon
1892
CALL
Medtronic
MDT
$107B
$4K ﹤0.01%
100
MGPI icon
1893
PUT
MGP Ingredients
MGPI
$378M
$4K ﹤0.01%
8,300
VEEV icon
1894
PUT
Veeva Systems
VEEV
$30.3B
$4K ﹤0.01%
10,800
SPLK
1895
CALL
DELISTED
Splunk Inc
SPLK
$4K ﹤0.01%
1,000
AGN
1896
CALL
DELISTED
Allergan plc
AGN
$4K ﹤0.01%
700
GLOWE
1897
DELISTED
GLOWPOINT INC
GLOWE
$4K ﹤0.01%
32,500
+2,500
+8% +$308
ADBE icon
1898
CALL
Adobe
ADBE
$89.5B
$3K ﹤0.01%
400
-100
-20% -$25.2K
BHC icon
1899
CALL
Bausch Health
BHC
$1.65B
$3K ﹤0.01%
200
-1,000
-83% -$23.9K
CVS icon
1900
CALL
CVS Health
CVS
$137B
$3K ﹤0.01%
1,100
-400
-27% -$24.7K

Similar funds

Creative Planning's Q1 2019 Portfolio in Review

As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.

By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.

  • Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
  • Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
  • Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
  • Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
  • Creative Planning opened 217 new positions and closed 175 in Q1 2019.
  • Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.

Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.